Using ex vivo machine perfusion - maintaining organs outside the body on a perfusion system - a novel platform was developed to enable genetic engineering of whole tissues prior to transplantation.

Solid tumors are heterogeneous with an immunosuppressive tumor microenvironment, but that is not slowing the search to treat the most difficult, recalcitrant cases ...

Prominently featured in The Inner Circle, Guy Plunkett, III, PhD is acknowledged as a 2026 Life Achiever Pinnacle Professional Member Inner Circle of Excellence for his contributions to Advancing ...

Spread the loveIn a bold move that underscores Texas’s growing significance in the biotech sector, Ben Lamm, the visionary behind the $10 billion-valued Colossal Biosciences, has launched a new ...

A US-based artificial intelligence company is bringing its technology to Australian researchers after the federal government ...

At first, the next century looks like a familiar list of threats: war, pandemics, AI, climate change, and disaster. But the ...

MIT Technology Review discovered that the stealth startup’s founder John Schloendorn also pitched a startling, medically ...

Neion Bio views its Raptor technology platform as harnessing “nature’s most powerful molecular factory—the egg." ...

In their landmark 1961 paper on the lac operon, Nobel laureates François Jacob and Jacques Monod speculated that RNA might ...

Researchers engineered fungal compounds that resist liver breakdown and effectively clear amebiasis in animal models. The ...

A new technique may reprogram immune cells inside the body, offering faster, simpler, and more accessible cancer treatment.

Understanding gene expression within the body has been a boon for 21st century biology and therapeutics, but most discoveries ...